Nahdi Medical Future Growth
Future criteria checks 3/6
Nahdi Medical is forecast to grow earnings and revenue by 7.7% and 5.1% per annum respectively. EPS is expected to grow by 6.4% per annum. Return on equity is forecast to be 36.4% in 3 years.
Key information
7.7%
Earnings growth rate
6.4%
EPS growth rate
| Consumer Retailing earnings growth | 9.3% |
| Revenue growth rate | 5.1% |
| Future return on equity | 36.4% |
| Analyst coverage | Good |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25
Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence
Jan 07Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report
Aug 07Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jul 25Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Mar 22Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings
Dec 13We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve
Aug 20Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?
Aug 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10,168 | 1,036 | 1,052 | 1,742 | 5 |
| 12/31/2025 | 9,574 | 961 | 911 | 1,665 | 7 |
| 12/31/2024 | 9,109 | 893 | 899 | 1,551 | 7 |
| 12/31/2023 | 8,714 | 893 | 984 | 1,369 | N/A |
| 9/30/2023 | 8,638 | 850 | 1,315 | 1,647 | N/A |
| 6/30/2023 | 8,634 | 891 | 1,066 | 1,371 | N/A |
| 3/31/2023 | 8,642 | 895 | 1,435 | 1,721 | N/A |
| 12/31/2022 | 8,616 | 888 | 1,393 | 1,668 | N/A |
| 9/30/2022 | 8,451 | 903 | 1,248 | 1,524 | N/A |
| 6/30/2022 | 8,334 | 897 | 1,277 | 1,555 | N/A |
| 3/31/2022 | 8,165 | 855 | 1,117 | 1,391 | N/A |
| 12/31/2021 | 8,066 | 813 | 1,028 | 1,334 | N/A |
| 9/30/2021 | 8,079 | 836 | 1,329 | 1,621 | N/A |
| 6/30/2021 | 8,173 | 682 | 1,428 | 1,721 | N/A |
| 3/31/2021 | 8,363 | 750 | 1,490 | 1,818 | N/A |
| 12/31/2020 | 8,642 | 849 | 1,266 | 1,586 | N/A |
| 12/31/2019 | 7,825 | 692 | 1,114 | 1,348 | N/A |
| 12/31/2018 | 7,350 | 611 | 797 | 980 | N/A |
| 12/31/2017 | 7,056 | 721 | 733 | 911 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4164's forecast earnings growth (7.7% per year) is below the savings rate (14.3%).
Earnings vs Market: 4164's earnings (7.7% per year) are forecast to grow faster than the SA market (6.6% per year).
High Growth Earnings: 4164's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4164's revenue (5.1% per year) is forecast to grow faster than the SA market (-0.3% per year).
High Growth Revenue: 4164's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4164's Return on Equity is forecast to be high in 3 years time (36.4%)